B

BioRelix

50 employees

BioRelix is engaged in the discovery and development of anti-biotic drug candidates for the treatment of infectious diseases.

Basic info

Industry

pharmaceutical manufacturing

Sectors

Biotechnology
Pharmaceutical
Biopharma

Date founded

2005

Funding rounds raised

Total raised

$26M

from 5 investors over 5 rounds

B

BioRelix raised $2.6M on March 22, 2012

Investors: Whole Genome Mapping @ OpGen, Inc and New Leaf Venture Partners

B

BioRelix raised $26M on June 11, 2007

Investors: Aisling Capital, Elm Street Ventures and New Leaf Venture Partners

FAQ